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This paper presents an investigation of the
retention of environmental radon daughters, 210Po
(alpha particle emitting radio-nuclide) and 210Bi
(beta particle emitting radio-nuclide), in lipid and
protein fractions of the cortical grey and
subcortical white matter from the frontal and
temporal brain lobes of patients who had suffered
from Alzheimer’s disease or Parkinson’s disease,
of cigarette smokers, and of control subjects.
210Po and 210Bi radioactivity increased tenfold in
the cortical grey and subcortical white protein
fraction in patients with Alzheimer’s disease and
smokers, and tenfold in the cortical grey and
subcortical white lipid fraction in patients with
Parkinson’s disease. Free radicals generated by
radon daughters may add to the severity of the
radio-chemical injury to the brain astrocytes. The
pathognomonic distribution of radon daughters to
lipids in patients with Parkinson’s disease and to
proteins in patients with Alzheimer’s disease was
attributed to high chlorine affinity of radon
daughters. The changes in the membrane protein
pores, channels, and gates in patients with
Alzheimer’s disease and in the lipid bilayer in
patients with Parkinson’s disease are at the core
of what the authors think are two systemic brain
diseases.
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Radon (222Rn) is a highly lipid-soluble, radioactive, and noble gas, ubiquitous in the
human environment (1). When inhaled, environmental 222Rn has a preference to ac-
cumulate in the lipid tissue throughout the body with the highest concentration in the
brain, and bone marrow (2, 3). Pohl and Pohl-Ruling (4) found that one third of the
inhaled radon decay products passes from the lungs into the bloodstream, which
indicates that radon gas does not flow quickly in and out of the lungs, but can linger
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long enough to allow radiation damage the body. Indeed, Lykken and co-workers (5,
6) showed that inhaled 222Rn was rapidly absorbed from the lung into the body where
it tended to accumulate in the cranium, resulting in increased 214Bi gamma-ray emis-
sions and altered EEG signals.
Radon is chemically inert; however, it is radioactive and decays through a distinct
series of radioactive daughters before it ends up stable 206Pb (Table 1) (7). When
Table 1 Major products of 222Rn decay series and their characteristics (22)
Major radiation emissions (MeV)
Radionuclide Half-life Alpha Beta Gamma
222Rn 3.823 d 5.49 0.670 0.295
218Po 3.05 min 6.00 0.730 0.352
214Pb 26.8 min 1.02
 214Bi 19.7 min 1.0 0.609
1.51 1.12
3.26 1.764
214Po 164 µs 7.69
210Pb 22.3 y 0.015 0.047
0.061
210Bi 5.01 d 1.161
210Po 138.4 d 5.305
206P Stable
decaying, radon and its daughters (RDs) release high-energy alpha and beta particles,
or gamma radiation, strong enough to damage the cell (8). One should bear in mind
that as soon as the alpha particle is emitted from the decaying radon and the radon
daughter is born a chemical transmutation will take place. Indeed, all RDs, including
the biologically most relevant 210Pb, 210Bi, and 210Po, down to stable lead, are heavy
metals that are highly neurotropic and neurotoxic (9). In contrast to mother radon
which is a lipid-soluble gas, freely moving in and out of the brain despite the blood-
brain barrier, none of the transmuted heavy metal RDs are lipid-soluble. Hence, they
remain trapped in the brain where they emit additional gamma radiation and alpha
and beta particles over their lifetime, thus adding up chemical to the radiation dam-
age to the brain.
The effect of constant low-level radiation exposure to large alpha particles of
high linear energy transfer such as 222Rn and 210Po on cognitive functions in the
human brain is unknown. Studies on children of atom bomb survivors in Japan who
had been irradiated in-utero showed that they scored lower on IQ tests (10). The
deleterious effects of high-energy radiation on the brain are already recognised in the
classification of the Diagnostic and Statistical Manual of Mental Disorders and coded
as »294.1 dementia due to intracranial radiation« (11). Indeed, subjects exposed to
lethal radiation doses showed profound psychological impairment without subsequent
pathological changes in the brain (12).
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Relying on the original observation on radon accumulation in the cranium by
Lykken and co-workers (5, 6), the objective of this study was to comparatively anal-
yse the pattern of distribution of natural environmental RDs – 210Po as a strong alpha
particle emitter (5.3 MeV) and 210Bi as a moderately strong beta particle emitter (1.2
MeV) – in the protein and lipid fractions of the cortical grey and subcortical white
matter from the frontal and temporal lobes of the brains taken from deceased pa-
tients who had suffered from Alzheimer’s disease (AD) or Parkinson’s disease (PD),
and from deceased smokers and nonsmokers (controls) who had never shown a sign
of neurological disease. Because the concentration of RDs is high in cigarette smoke




Brain samples from deceased patients who had suffered from Alzheimer’s disease
(AD) or Parkinson’s disease (PD), those who had smoked, and those who had shown
no known neurological disease in their lifetime were kindly provided by the Alzheimer’s
Research and Treatment Center in St. Paul, MN. The pathological diagnosis of AD
relied on the presence of an age-adjusted moderate to severe number of plaques in
the neurocortex (14). We received samples from the frontal and/or temporal lobes
from the brains: 11 AD, six PD, four smokers, and eight nonsmokers (controls). Age
and sex distribution was similar between the groups except for the cigarette smokers
who were slightly younger (Table 2). We altogether analysed 45 brain lobe samples of
29 subjects, 25 from the frontal lobe and 20 from the temporal lobe. In each group
there were four subjects from whom we had both frontal and temporal lobe available
for the analysis (Table 2). Before the analysis, the brain slices weighing approximately
80 g had been frozen in liquid nitrogen and stored for ten years on average. Long
enough to reach secular equilibrium between the 210Po formed in the brain from 210Bi
directly and from 210Pb indirectly via 210Bi, as 210Bi and 210Po can come about only
through the decay of 222Rn.
We separated cortical grey and subcortical white matter from each frontal and
temporal lobe. One gramme of each sample was fractionated into protein and lipid
content before we assessed 210Bi and 210Po activity. Subcortical white matter was
sampled 0.5 cm orthogonally below the sampled cortical grey matter area. Three
replicates of each lipid and protein fraction were prepared from grey and white matter
from every brain lobe.
Trichloracetic acid soluble fraction
Unless specified otherwise, all chemicals used in this study were reagent grade and
supplied by Fisher Scientific, Ithaca, IL. Only distilled H2O was used.
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First we separated grey and white cortical matter (A. L. Politoff, personal com-
munication). One gramme of either grey or white matter was homogenised at 4 ºC
in a Potter-Elvehjem glass-Teflon tissue homogeniser with 6 ml of distilled H2O and
0.5 ml of 100% trichloracetic acid. After centrifugation at 5,000 rpm (CRU-5000
Centrifuge, Hamden Heights, MA) for 10 min, the supernatant was poured off and
saved in a 20 ml plastic tube. After vigorous mixing of the precipitate in 2 ml of H2O,
the extraction procedure was repeated. The supernatant fluids were pooled and la-
belled as trichloracetic acid soluble fraction. This fraction contains primarily nucle-
Table 2 Brain proteins (mg/g). Subjects are arranged according to their age at the moment of death
Brain lobe protein (mg/g brain tissue)
Temporal Frontal
No. Age Sex Grey White W/G Grey White W/G
CONTROL
1 52 M 148.3 70.7 0.477 159.6 93.7 0.587
2 53 M 150.6 72.3 0.480 181.4 74.4 0.410
3 60 M 105.3 97.3 0.924
4 70 F 149.7 71.2 0.476 170.5 89.8 0.527
5 70 M 150.9 69.8 0.462
6 76 F 152.1 71.4 0.469 138.5 86.5 0.624
7 79 M 217.4 71.4 0.328
8 88 M 233.8 123.2 0.527
ALZHEIMER’S DISEASE
9 62 F 126.8 42.7 0.337
10 66 M 128.1 63.2 0.493
11 71 F 189.7 68.8 0.363 172.1 94.4 0.548
12 73 M 206.0 54.4 0.264
13 80 F 213.5 48.4 0.227
14 82 M 158.8 70.1 0.441
15 82 F 160.4 78.4 0.489 191.7 49.0 0.256
16 84 F  89.9 44.7 0.497 126.2 59.8 0.474
17 85 M 233.8 102.2 0.437
18 86 F 100.4 51.2 0.510 108.4 53.4 0.493
19 93 F 120.6 59.1 0.490
PARKINSON’S DISEASE
20 68 M 148.4 107.8 0.726 158.7 73.5 0.463
21 71 M 199.6 56.6 0.283 224.0 60.9 0.272
22 73 F 181.4 81.4 0.449
23 77 F 147.8 75.7 0.512
24 80 M 366.6 138.9 0.379 224.0 155.8 0.695
25 81 F 204.0 107.6 0.527 165.2 56.4 0.341
SMOKERS
26 47 F 171.7 68.7 0.400 171.9 81.9 0.476
27 68 M 101.3 49.3 0.487 131.6 68.8 0.524
28 72 F 102.6 54.4 0.530 141.3 72.4 0.512
29 79 M  99.5 43.7 0.439 123.7 64.7 0.523
M – male, F – female; G – cortical grey brain matter, W – subcortical white
brain matter,  W/G – ratio between the White and Grey matter protein fractions
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otide and other small molecular weight compounds. They were found to be essential-
ly free of all RDs.
Extraction of lipids
Lipids were extracted from the trichloracetic acid precipitate according to the method
of Folch and co-workers (15) by using chloroform:methanol (2:1 vol./vol.). The pre-
cipitate was mixed with a 3 ml methanol for one minute. After 10 minutes, 6 ml
chloroform was added. After centrifugation, the supernatant was filtered through sin-
tered glass (medium porosity). The precipitate was rinsed with 4 ml of Folch reagent
and the filtrates combined. Biphasic separation was achieved upon addition of 1 ml
potassium acetate. The upper aqueous layer was removed and discarded. The organ-
ic phase was taken to dryness under a stream of nitrogen at room temperature. The
total lipids were dissolved in a 1 ml chloroform. Any residual proteins were removed
by filtration through glass wool and the lipid fraction was divided in two equal por-
tions, one for alpha spectroscopy and other for beta-scintillation spectrometry. All
calculations based on amount of total lipid extracted from one gram of tissue.
Protein fraction
The protein precipitate which remained on the sintered glass was dissolved in 1 ml
0.1 M NaOH at 75 ºC over night (16). The protein fraction was divided in three equal
portions; one to assess the amount of protein, and one each for alpha and beta
activity analysis. The amount of protein was quantitatively assessed employing Brad-
ford’s reagent (Bio-Rad Laboratories, Hercules, CA). After addition of the reagent,
absorbency was measured employing a Beckman spectrophotometer at 760 nm (Beckman
Instruments Co., Fullerton, CA). Bovine albumin (Bio-Rad Laboratories, Hercules, CA)
served as a standard.
Low level alpha particle counting
Alpha particles were measured with an Alpha Spectrometer System (EG&G ORTEC,
Oak Ridge, TN) using a radionuclide library software package from the same manu-
facturer. This computer-controlled system consists of five separate surface barrier
alpha spectrometers with alpha resolution of 6 KeV, which allows for accurate dis-
crimination of 208Po, 209Po, and 210Po isotopes. The detection limit of the instrument
was 10 µBq per gramme of brain tissue. Every week, a 48-hour naturally occurring
background was measured at the photo peak value for every detector and isotope,
i.e., 208Po (5.115 MeV), 209Po (4.880 MeV), and 210Po (5.305 MeV) (17).
Silver disk sample spiking and plating
We essentially followed the method of P.O. Jackson, which was developed at Battelle
Pacific Northwest Laboratories (18). Polonium has a high selective affinity for silver.
Hence, one-inch silver disks (HH Lucas-Milhaupt, Inc, Cudahy, WI) were painted on
one side with black Krylon spray paint (Home of Economy, Grand Forks, ND); the
other side was polished, rinsed and placed in the plating apparatus described below.
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To determine recovery (percent), the samples were »spiked« with a standard
stock solution of 208Po of known activity (1606 Bq/ml, Isotope Products Laboratories,
Burbank, CA). The standard stock solution was diluted with 0.4 N HCl so that each
sample was spiked with 208Po yielding 1 disintegration per minute (dpm) per 10 µl.
The error of pipetting was ±2%. The background for each polonium peak of any of
the silver disks did not exceed 2 counts per 48 hours.
To destroy organic matter, the spiked samples were placed in a 250 ml beaker
and digested in a 10 ml concentrated HNO3. After heating at 85 ºC for 30 min, 10 ml
of 30% hydrogen peroxide and 3 ml of concentrated HNO3 were added and the
solution heated to dryness (30 min). The procedure was repeated 3 times before 5 ml
of 12 M HCl and 5 ml of distilled H2O were added to the dry sample to form polo-
nium chloride. The solution was heated at 85 ºC until dry and dissolved in 120 ml of
distilled H2O containing 10 mg of ascorbic acid. To allow for plating of the polonium
on the silver discs, the pH was <2. Low pH enhances extraction of any cation. To
plate the polonium, the silver disk was placed in a Teflon holder, which was immersed
in the solution of the spiked sample from either grey or white matter. The beaker was
placed on a stirring hot plate at 85 ºC and the solution stirred at 2.5 Hz. The 208Po
and 209Po from the spike and unknown 210Po from the sample were allowed to plate
out over a 6–8 hour period, after which time the disk was removed, rinsed with
distilled H2O, and counted for alpha activity for 48 hours.
Separation of 210Pb from 210Bi and 210Po
We essentially followed the method of Orlandini and co-workers, which was devel-
oped at the Argonne National Laboratory (19, 20). The lipid or protein fractions were
passed through a polymembrane under a negative pressure gradient (6 ml/min). The
polymembrane consists of two negatively charged ion exchange membranes (Gelman
Sciences, Ann Arbor, MI) which constitute a special system for absorption of 210Bi and
210Po. The two readily form oxichlorides which bind to the membrane, whereas 210Pb
is selectively filtered. The membranes were dried prior to alpha particle analysis or
rinsed with 0.4 mol/L HCl and placed in a 20 ml vial for the assessment of beta
emission.
Alpha radioactivity
The standard 208Po and sample 210Po counts under the peaks were summed separate-
ly. The background counts were subtracted from the sample counts to obtain the net
counts for each isotope. 210Po and 208Po net counts were corrected for decay and
210Po counts were extrapolated to the time of the patient’s death. The final activity was
expressed as 210Po disintegration per minute (dpm)/g brain tissue. Two replicates of
each brain sample were prepared for alpha counting.
210Pb decays to 210Bi which, in turn, decays to 210Po; each at a different decay
rate (Table 1). After 600 days a »secular equilibrium« is reached, meaning that the
activities of both the 210Bi and 210Po in the sample are equal to the 210Pb activity.
Therefore, from the time of the brain sampling postmortem to the time of 210Po
plating on Ag disks, 210Po formed in the brain from 210Bi directly and from 210Pb
indirectly via 210Bi. We used the standard Bateman differential equation of growth and
decay of radionuclides in a decay chain to correct for this contribution (21, 22).
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Blanks were prepared separately by spiking silver disks with 10 µL of 208Po and mea-
suring them in the same way as brain samples. The 208Po recovery after plating was
85±3%. The alpha particle dpm for all the brain samples fell within ±2 SD.
Beta radioactivity
Low-level beta liquid scintillation counting (LSC) involved the following procedure; 10
ml of liquid scintillation cocktail solution (Beckman Co., Fullerton, CA) were added to
the sample and the activity measured in a Beckman scintillation spectrometer (Beck-
man Co., Fullerton, CA). The detection limit of the instrument was 10 µBq per g of
the brain tissue. As outlined above, 210Bi beta activity in the sample is an excellent
measure of the 210Pb activity, since 210Pb, 210Bi, and 210Po were in secular radioactive
equilibrium in each brain several years after the death of the subjects. This is why the
calculations for a three-component chain decay followed the same procedure as the
alpha particle counting. The efficiency of binding of 210Po and 210Bi to the membrane
was assessed with a 210Pb standard (Battelle Pacific Northwest Laboratories, Richland,
WA), and found to be 68% and 99%, respectively. The technique is similar to that of
measuring the activity of caesium in seawater (23) and it gave the same values as
those reported by the Argonne National Laboratory (20).
Statistical analysis
Measurements of alpha and beta activities were expressed as dpm/g of brain tissue. This
allows for direct comparison of instruments with different counting efficiency and hence
for direct comparison of two different methods of analysis, i.e., alpha and beta counting.
In other words, beta (210Bi) and alpha (210Po) dpm served as standards for each other.
All samples were counted until the number of counts above background exceed-
ed 400. This is well above the minimum criteria for accurate measurement at the 5%
probability level (signal to noise ratio) defined here as 100% times the square root of
the net counts above background and divided by the net counts. Thus the net counts
exceeded 400. This satisfies the accuracy criterion that the standard error (the square
root of the number of counts) does not exceed 5% of the measurement (24). Currie
(25) has suggested that a net signal of 10 sigma background is satisfactory for
quantitative measurements. However, Currie’s signal was broad and contained a large
number of counts whereas our signal was very narrow and contained only zero, 1, or
2 counts at most over a 48-hour counting period. Therefore, we choose 3 sigma
background as the significant level (24). The entire data set on 210Bi and 210Pb is
shown in Appendix I, Parts A–C.
Statistical analysis searched for possible dependence of radiation level on measure-
ment method (alpha or beta-radiation), brain fraction (lipid or protein), brain lobe (frontal
or temporal), brain matter (grey or white), subject type (AD, PD, smoker, or control), and
interactions of these effects. We used multivariate analysis of variance (MANOVA) with
subject type as a between-subjects effect (factor) and all other effects as within-subject
effects (contrasts of the response variables). The radiation level was log-transformed to
approximate normality (however, Figures 1–4 below show untransformed data).
Neither the alpha-beta main effect nor any interactions involving this factor were
significant at the 0.05 level (Table 3). Hence, alpha and beta measurements were
averaged and a second MANOVA was performed on the remaining factors. In this
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Table 3 Comparison between alpha 210Po and beta 210Bi specific activities (AB) in proteins and
lipids from the cortical grey and subcortical white (GW) matter from the frontal and temporal brain
lobe (FT) in patients with Alzheimer’s disease, Parkinson’s disease, smokers, and controls using
the multivariate analysis of variance (MANOVA)
Effect DF P
AB 1 NS
AB * FT 1 NS
AB * GW 1 NS
AB * PL 1 NS
AB * CAPS 3 NS
AB * FT * GW 1 NS
AB * FT * PL 1 NS
AB * FT * CAPS 3 NS
AB * GW * PL 1 NS
AB * GW * CAPS 3 NS
AB * PL * CAPS 3 NS
AB * FT * GW * PL 1 NS
AB * FT * LP * CAPS 3 NS
AB * GW * PL * CAPS 3 NS
AB * FT * GW * PL * CAPS 3 NS
FT 1 NS
FT * GW 1 <0.0001
FT * PL 1 <0.0002
FT * CAPS 3 NS
FT * GW * PL 1 NS
FT * GW * CAPS 3 <0.0001
FT * PL * CAPS 3 <0.005
FT * GW * PL * CAPS 3 NS
GW 1 <0.0017
GW * PL 1 NS
GW * CAPS 3 NS
GW * PL * CAPS 3 <0.0456
PL 1 <0.0001
PL * CAPS 3 <0.0001
CAPS 3 <0.0001
Legend:
A – alpha activitiy P – protein
B – beta activitiy L – lipids
F – frontal lobe C – controls
T – temporal lobe A – patients with Alzheimer’s disease
G – grey brain matter P – patients with Parkinson’s disease
W – white brain matter S – cigarette smokers
NS – not significant CAPS – controls, to Alzheimer’s disease, Parkinson’s
disease, and cigarette smokers
analysis, the subject type-lobe-grey/white and subject type-grey/white-protein/lipid interac-
tions were significant, indicating non-additivity of effects on a log scale (Table 4). There-
fore, the eight measurements defined by combinations of lobe, grey or white matter, and
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protein or lipid, were examined separately as response variables in one-way analysis of
variance with subject type as the independent variable. Differences among subject types
were highly significant in all eight cases (P ranged from 0.001 to 0.006). Pairwise
comparisons were made using Fisher’s protected t procedure with the significance set
at 0.05 (26). All analyses were run on SAS, Version 6.11 (SAS Institute Inc., Cary, NC).
Table 4 Multivariate analysis of variance
Effect DF P
FT 1 NS
FT * GW 1 <0.0001
FT * PL 1 <0.0005
FT * CAPS 3 NS
FT* GW * PL 1 NS
FT * GW * CAPS 3 <0.025
FT * PL * CAPS 3 NS
FT * GW * PL* CAPS 3 NS
GW 1 <0.005
GW*PL 1 NS
GW * CAPS 1 NS
GW * PL * CAPS 3 <0.01
PL 1 <0.0001
PL * CAPS 3 <0.0001
CAPS 3 <0.0001
Legend:
DF – degrees of freedom
NS – not significant
FT – frontal and temporal cerebral lobe
GW – grey and white brain matter
PL – proteins and lipids
CAPS – controls, Alzheimer’s disease, Parkinson’s
disease, and cigarette smokers
RESULTS
The amount of protein in the frontal and temporal brain lobe ranged from 75.7 to
366.6 mg/g grey matter tissue and 42.7–155.8 mg/g white matter tissue. The amount
of protein in the grey matter was approximately twice as high in the white matter. The
average ratio of white to grey matter protein for the 45 analysed brain samples was
(mean±SD) 0.470±0.126 and the coefficient of variation was approximately 25%, a
reasonable value considering the biological variability of the subjects and the limits of
the analytical methodology involved.
Two different radio analytical techniques showed no difference between alpha
(210Po) and beta (210Bi) activity. Consequently, the values of 210Po and 210Bi were
averaged for further analysis (Table 3). The analysis of these averaged measurements
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revealed some three-way interactions (Table 4). Such high-order statistical interac-
tions make interpretation difficult and are usually ignored in the analysis of the effect.
In spite of non-additivity of effects, the relationships between subject type, brain frac-
tion, and grey/white matter appear very similar in the frontal (Fig. 1) and the temporal
(Fig. 2) lobes (Table 5). One-way ANOVA revealed that the deposition of 210Bi and
210Po in the brain has a distinct, pathologically based distribution in the protein (Fig 3)
Figure 1 Frontal lobe. 210Po and 210Bi in protein (P) and lipid (L) fractions from the cortical grey (G)
and subcortical white (W) matter from the frontal (F) brain lobe in Alzheimer’s disease, Parkinson’s
disease, smokers, and controls. The box-and-whisker plots. The horizontal line inside the box
represents the median. The lower boundary of the box is the 25th percentile and the upper boundary
is the 75th percentile. The vertical lines (whiskers) show the largest and the smallest observed
values that aren’t outliers. Cases with values that are more than 3 box lengths from the upper or
lower edge of the box are extreme values (*). Cases with values that are between 1.5 and 3 box
lengths from the upper or lower edge of the box are outliers (o) (SPSS for Windows, SPSS Inc.,
Chicago, IL 1993)
and lipid (Fig. 4) fractions. The retention of the radionuclides was the lowest in the
control brains. In contrast, radioactivity of both RDs in AD brains was about an order
of magnitude, that is, ten times higher in the protein fraction of both grey and white
matter than in the control brains. Some of the AD brains also manifested somewhat
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Figure 2 Temporal lobe. 210Po and 210Bi in the protein (P) and lipid (L) fractions from the cortical grey
(G) and subcortical white (W) matter from the temporal (T) brain lobe in Alzheimer’s disease,
Parkinson’s disease, cigarette smokers, and controls (see Fig.1 legend for explanation)
Table 5 Pairwise comparisons of concentrations of radioactive radon daughters in proteins (P) and
lipids (L) in the cortical grey (G) subcortical white (W) brain matter from frontal (F) and temporal (T)
brain lobe in Alzheimer’s disease (AD), Parkinson’s disease (PD), cigarette smokers (S)
and controls (C)*
FG FW TG TW FG FW TG TW
C vs. AD P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 NS NS P<0.05
C vs. PD NS NS NS P<0.05 P<0.05 P<0.05 P<0.05 P<0.05
C vs. S P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05
AD vs. PD P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05
AD vs. S NS P<0.05 NS P<0.05 NS NS NS NS
PD vs. S P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05
* Fisher’s protected t-test
Legend: F – frontal lobe; T – temporal lobe; G – grey brain matter; W – white brain matter;
NS – not significant
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increased radioactivity in the lipid fraction, but the increases were much smaller and
statistically significant only for the frontal grey and temporal white matter.
However, the radioactivity in the lipid fraction of the cortical grey and subcortical
white matter of both the frontal and temporal lobes in PD were approximately an
order of magnitude higher than that of controls, while increases in radioactivity in the
protein fraction were much smaller and significant only for the white matter of the
temporal lobe. As in AD, the radioactivity greatly increased in the protein fraction and
somewhat in the lipid fraction of the smokers’ brains. Unlike AD, however, the smok-
ers did not show any increase of the activity in the lipid fraction of the brain grey
matter (Table 5).
Figure 3 Protein. 210Po and 210Bi in the protein fraction (P) from the cortical grey (G) and subcortical
white (W) matter from the frontal (F) and temporal (T) brain lobe in Alzheimer’s disease, Parkinson’s
disease, cigarette smokers, and controls (see Fig.1 legend for explanation)
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Figure 4 Lipid. 210Po and 210Bi in the lipid fraction (L) from the cortical grey (G) and subcortical white
(W) matter from the frontal (F) and temporal (T) brain lobe in Alzheimer’s disease, Parkinson’s
disease, cigarette smokers, and controls (see Fig.1 legend for explanation)
DISCUSSION
The results of our study showed that, indeed, there is residual RD radioactivity in the
brain, that RDs accumulate ten times as much in the diseased AD and PD brains,
and even more in those of smokers, as in the control brains, that this accumulation
is not random or uniform, but shows selective, disease-dependent distribution to the
protein fraction of the cortical grey and subcortical white brain matter in AD and
smokers, and to the lipid fraction in PD, and that the same results were obtained by
two different radioanalytical techniques, that is, one for alpha particles (210Po) and the
other for beta particles (210Bi).
The reliability of the data and the strength of the statistical analysis are greatly
enhanced because each sample was analysed in multiple replicates and above all,
with two different radio-analytical methods involving the respective alpha and beta
particles (27). Indeed, both analytical methods yielded the same selective pattern of
RDs distribution in the proteins and lipids of cortical grey and subcortical white brain
matter within the groups of subjects who suffered from AD, PD, smoking, and in the
controls. It is important to note that the radioactivity in the lipids was approximately
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the same for the cortical grey and subcortical white brain matter in spite of their
presumably different fatty acid composition (28). The congruency of the radioanalyt-
ical results further meant that the samples were indeed in a »secular equilibrium«; yet
another check of the accuracy of the radio-analytical work. These data explicate that,
in fact, both AD and PD are systemic brain diseases which result from the impaired
protein biochemical structure in the former and that of the lipids in the latter case.
Perhaps they indicate the advanced stage of the disease in our patients (29) because,
thus far, clinical AD was generally associated with changes in the cholinergic projec-
tions of the limbic system in the Papez circuit (30) and PD with degenerative changes
and lack of dopamine from the substantia nigra (31). Thus, environmental radon
provided a naturally occurring marker which enabled us to differentiate between the
biochemical changes which underlie these two neuropathological conditions, that is,
AD and PD. Our data provide some support to the idea of the underlying genetic
origins of predisposition to the effect of the environmental toxicants in the aetiology
of AD and PD, similar to that assumed to link smoking and increased incidence of
lung cancer (32, 33).
Our further discussion will focus on an attempt to (a) elaborate more extensively
the possible risk of low-level high linear energy of environmental radon and RD alpha
and beta particle radiation to the brain cell population and (b) provide some logical
frame which may explain the selective pattern of RD distribution in the lipid and
protein fraction of the brain in PD and AD and smokers, respectively.
Our study demonstrated that radon has a capacity to infest the brain with poi-
sonous progeny of radioactive heavy metals. Indeed, judging from data on environ-
mental radon which reaches the brain in the course of an average, 70-year human life
and from the number and size of cells in a 1.5 kg brain, there are enough high-energy
alpha particles to hit and damage every single cell in the brain more than once over
a lifetime (34). This adds to the tremendous potential for radiation-induced micro-
injury, point mutations, and deletions in gene expression (35, 36). The high-energy
alpha and beta particles exhibit deleterious biological effects along their pathway in
direct proportion to their initial energy (37, 38).
Along such alpha and beta particle »death path«, intensive ionisation will also
generate a large number of free radicals (12), as will the heavy metals generated from
the transmuted radon and its daughters. Free radicals will additionally harm the molecular
biological structures via protein oxidation, lipid peroxidation, and DNA intercalation
and impair the signal transduction, cell membrane function, and gene expression at
the cellular level (39–43). Today, it is considered that radiation is a zero-threshold
carcinogen which means that if no threshold exists, there is no dose – other than zero
– at which the risk of cancer is nil (44). Hence radon and its daughters in the brain
present a potential radiation hazard which may combine with other physical, chemi-
cal, and biological hazards to the brain (45). It should be noted that the health risks
of therapeutic doses of irradiation of the human brain are far above those of the low-
level exposure to the environmental radioactive RDs. Indeed, current limits of sensi-
tivity to indicate overexposure from acute irradiation are about 20–30 mSv (46).
The most likely candidates for the radiation injury appear to be the brain astro-
cytes and other glia cells which are highly radiosensitive in contrast to the more radio-
resistant neurons which do not divide (47, 48). Apparently, astrocytes supply the
neurons with proteins necessary for the formation of new dendritic connections (49)
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which are vital for the formation of new memories (50). Indeed, the astrocyte services
the neuron in numerous ways; it provides the neuron with many protein components
(51), removes potassium ions from the extracellular space following neuron depolar-
isation (29), collaborates in presynaptic firing of the neuron (52), and helps metal ion
excretion (53). The astrocyte is also peculiar in that it has many projections linking
the capillary endothelium cell and the neuron (54) which show up only when the
astrocyte is sessile in its location (55). When an astrocyte is injured, it becomes
mobile, leaves its position, and disrupts the complex three-dimensional cytoarchitec-
tonics of the brain (56). There is growing evidence of astrocyte involvement in AD;
ApoE, the major apolipoprotein in the nervous system which is essential for the neu-
ron function, is expressed in astrocytes and its »bad« E4 variant may interact abnor-
mally with neuronal cytoskeletal proteins favouring microtubule degradation and the
formation of neurofibrillary tangles which occur in the brains of people with Alzhe-
imer’s disease (57). Thus, the amyloid deposits and tangling observed in Alzheimer’s
disease may well reflect the response to injury of the astrocyte (58). This study hy-
pothesised that there was sufficient radioactivity and free radicals accompanying the
presence of radon and its daughters in the brain to act as an apogen and induce
such cascade (59, 60).
Our finding of selective, disease-specific patterns of RD accumulation in AD
proteins and PD lipids was quite unexpected. To paraphrase Sir Roger Bannister
(51), we found ourselves in the position where to meaningfully interpret the data was
indeed more difficult than to collect them. Ramon y Cayal and Golgi were the first
to exploit the metal-binding affinity of brain cells to make them histologically visible
(29). A century later, we found that nature did the same for us by marking with
environmental RDs different biochemical compartments in the brain, that is, proteins
of AD and lipids of PD. We found from other studies of radio-chemical affinity that
both polonium and bismuth have practically exclusive affinity for the chlorine ions to
form highly reactive oxichlorides over the pH range 1–10 (61, 62). We concluded that
the increased concentration of chlorine ions in the proteins and lipids in AD and PD,
respectively, would result in increased trapping of RDs. Indeed, chlorine is the major
extracellular cation in the brain (63). The increased trapping of chlorine ions would
most likely reflect the increase in chlorine intracellular concentration; via specific membrane
chlorine channels or those where chlorine is passively associated with sodium trans-
port (64).
But if there indeed is transmembrane chlorine leakage, how is that it occurs in
the proteins of AD and in the lipids of PD? We inferred that, in accordance with the
fluid mosaic model of the cell membrane structure (65), the pathognomonic distribu-
tion of the RDs to the lipids in PD and to the proteins in AD might reflect the disease-
related changes in the brain cell membrane. The changes involve the protein-built
pores, channels, and gates in AD and the lipid bilayer in PD, and are followed by
increased ionic leakage, which points at the impaired membrane potential, discharge,
and excitability. The nerve cells, then, do not necessarily need to be dead to allow for
chlorine leakage through the membrane. In other words, the impairment may be
partial and, perhaps, some of the cell membranes may self-repair and even recover
temporarily. This may further explain the ill-understood mechanism of the fluctuation
in the course of such systemic brain cell membrane diseases as AD and PD. It would
also explain why so many different aetiologic factors, from common cold to alumin-
362 Mom~ilovi} B. et al.: ENVIRONMENTAL RADON DAUGHTERS AND BRAIN DAMAGEArh hig rada toksikol, Vol 50 (1999) No 4, pp. 347–369
ium, can be associated with the onset of AD and PD. The brain requires about 20%
of cardiac output (66) and produces about ten times its own weight of ATP per day.
This huge amount of energy is mostly used for proper membrane function (67). It is
not, then, surprising that the change of the dynamic properties of the cell membrane
and transfer of the ions and neurotransmitter have already been suggested as the
underlying principle of a wide range of neurological disorders (68–70). Indeed, the
observed 10 times higher retention of radioactive heavy metal 203Pb in the brain of a
suckling, compared to that of adult rats (71), may be related to age-dependent im-
maturity of functional integrity of the neuron’s membrane.
In contrast to the peripheral nervous system (52, 72), we were surprised to find
how little is known about the supposedly cholinomimetic effects of nicotine, that is,
smoking on central nervous system, except that nicotine can »excite motor cortex
and stimulate our cognitive capabilities« (73). In our study, smokers had the highest
activity of 210Po and 210Bi in the protein fraction of the brain grey and white matter.
We think that this finding further supports our chlorine hypothesis, because nicotine
is most likely to bind to specific protein receptors (74) and thus temporarily hyperpo-
larise the membrane via intracellular influx of chlorine ions. In other words, the effects
of nicotine on the central nervous system may mimic those of the gamma-aminobu-
tyric acid more than that of acetylcholine. Incidentally, smoking (nicotine) is contrain-
dicated in the ulcerous gastric diseases, and nicotine receptors in the stomach are
also related to the handling of the chlorine ions (75). We had only one AD patient
who had also been a smoker (those radioactivity values were not included in the
tables or calculations). However, his brain concentration of 210Bi and 210Pb was inor-
dinately high, some 20–22 times the level found in controls. Many sub-structural
subtleties in the brain protein composition which are beyond the resolving power of
our method may be related to such a synergistic picture of RD accumulation. We did
not study the interaction between nicotine and protein, but our results for smokers
indicate that presumably easily volatile nicotine from cigarette smoke (76) may have
a direct access to specific receptor proteins of the cortical grey and subcortical white
brain matter.
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APPENDIX I. 210Po (alpha) and 210Bi(beta) specific activity in the brains from Alzheimer’s disease,
Parkinson’s disease, cigarette smokers and controls (disintegration/min/g).
Part A. 210Po in the protein (P) and lipid (L) fraction from cortical grey (G) and subcortical white (W)
brain matter from the frontal lobe (F). (a and b are replicates).
Subject FGPa FGPb FGLa FGLb FWPa FWPb FWLa FWLb
CONTROL
1 0.00710 0.00720 0.00493 0.00499 0.00630 0.00620 0.00420 0.00440
2 0.00470 0.00490 0.00410 0.00398 0.00372 0.00370 0.00279 0.00284
3 0.00910 0.00880 0.00814 0.00823 0.00920 0.00890 0.00880 0.00910
4 0.00480 0.00490 0.00423 0.00443 0.00443 0.00439 0.00297 0.00330
5
6 0.00420 0.00400 0.00352 0.00354 0.00259 0.00610 0.00230 0.00240
7 0.00698 0.00690 0.00587 0.00592
8
ALZHEIMER’S DISEASE
9 0.04430 0.03968 0.00193 0.00200 0.00680 0.00730 0.00300 0.00260
10 0.05780 0.06180 0.00960 0.01000 0.00890 0.00870 0.00360 0.00420
11 0.02680 0.02717 0.00960 0.01050 0.01790 0.01820 0.00770 0.00830
12 0.01100 0.00830 0.01870 0.01900 0.00940 0.01070 0.01100 0.00800
13 0.08690 0.09290 0.01090 0.01690 0.01200 0.00930 0.00710 0.00730
14 0.10830 0.10960 0.09230 0.08800 0.04100 0.03310 0.00800 0.01100
15 0.06880 0.06970 0.04410 0.03000 0.00890 0.00960
16 0.04230 0.02990 0.00870 0.00940 0.00840 0.00790 0.00430 0.00440
17
18 0.09600 0.09900 0.01200 0.00790 0.01960 0.02400 0.00790 0.00850
19
PARKINSON’S DISEASE
20 0.00880 0.00820 0.07100 0.06500 0.00560 0.00570 0.02100 0.01500
21 0.00850 0.00810 0.07300 0.05670 0.01040 0.00750 0.04870 0.05090
22 0.00850 0.00910 0.06900 0.07700 0.00630 0.00580 0.02400 0.01800
23 0.04400 0.04900 0.00940 0.00890
24 0.00190 0.00490 0.09500 0.08800 0.00870 0.00890 0.01770 0.01820
25 0.06700 0.06300 0.00580 0.00620 0.05800 0.06400
CIGARETTE SMOKERS
26 0.07310 0.07150 0.00960 0.01450 0.04920 0.04680 0.00770 0.00820
27 0.08840 0.08940 0.01796 0.01800 0.05380 0.05430 0.00960 0.00990
28 0.07960 0.08240 0.01040 0.00810 0.07180 0.07230 0.00720 0.00710
29 0.10900 0.08750 0.01990 0.02810 0.05960 0.06030 0.00950 0.01090
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APPENDIX I. 210Po (alpha) and 210Bi (beta) specific activity in the brains from Alzheimer’s disease,
Parkinson’s disease, cigarette smokers and controls (disintegration/min/g).
Part B. 210Po in the protein (P) and lipid (L) fraction of cortical grey (G) and subcortical white (W)
brain matter from the temporal lobe (T) (a and b controls are replicates).
Subject TGPa TGPb TGLa TGLb TWPa TWPb TWLa TWLb
CONTROL
1 0.00746 0.00748 0.00390 0.00390 0.00380 0.00366 0.00310 0.00289
2 0.00649 0.00651 0.00321 0.00320 0.00428 0.00430 0.00354 0.00357
3
4 0.00589 0.00567 0.00310 0.00290 0.00398 0.00390 0.00327 0.00329
5 0.00732 0.00783 0.00449 0.00448 0.00513 0.00516 0.00369 0.00380
6 0.00510 0.00530 0.00297 0.00299 0.00390 0.00413 0.00330 0.00300
7








15 0.07740 0.07680 0.00134 0.00111 0.05920 0.05560 0.00770 0.00860
16 0.06230 0.06180 0.00880 0.00860 0.04760 0.04920 0.00776 0.00780
17 0.08670 0.08740 0.00980 0.01190 0.06713 0.06550 0.00930 0.00880
18 0.09280 0.09330 0.00156 0.00150 0.07270 0.06870 0.01280 0.01320
19 0.06920 0.06930 0.00940 0.01400 0.05340 0.04850 0.00800 0.00670
PARKINSON’S DISEASE
20 0.00860 0.00930 0.02970 0.03190 0.00940 0.01080 0.01780 0.01800
21 0.00890 0.00910 0.00660 0.00739 0.00890 0.00970
22 0.00850 0.00810 0.07300 0.05670 0.01040 0.00750 0.04370 0.05290
23
24 0.04100 0.02870 0.02300 0.01310 0.06300 0.05690
25 0.00780 0.00830 0.02300 0.01480 0.00860 0.01090 0.01770 0.01820
CIGARETTE SMOKERS
26 0.08700 0.10900 0.00870 0.00770 0.07600 0.08200 0.00770 0.00720
27 0.13400 0.12700 0.00850 0.00920 0.09100 0.08600 0.00830 0.00740
28 0.09300 0.08800 0.00780 0.00830 0.09150 0.08670 0.00683 0.00690
29 0.15400 0.16500 0.00920 0.00980 0.09680 0.09710 0.00930 0.00870
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APPENDIX I. 210Po (alpha) and 210Bi (beta) specific activity in the brains from Alzheimer’s disease,
Parkinson’s disease, cigarette smokers and controls (disintegration/min/g).
Part C. 210Bi in the protein (P) and lipid (L) fraction of cortical grey (G) and subcortical white (W)
matter from the frontal lobe (F) and temporal lobe (T).
Subject FGP FGL FWP FWL TGP TGL TWP TWL
CONTROL
1 0.00690 0.00520 0.00580 0.00480 0.00720 0.00360 0.00410 0.00230
2 0.00950 0.00370 0.00330 0.00310 0.00660 0.00290 0.00450 0.00360
3 0.00860 0.00840 0.00950 0.00860
4 0.00510 0.00480 0.00460 0.00260 0.00620 0.00340 0.00370 0.00310
5 0.00750 0.00420 0.00490 0.00350
6 0.00380 0.00370 0.00220 0.00250 0.00560 0.00280 0.00430 0.00290
7 0.00710 0.00610 0.00190 0.00180
8 0.00290 0.00340 0.00380 0.00340
ALZHEIMER’S DISEASE
9 0.04700 0.00250 0.00770 0.00310
10 0.05520 0.01200 0.00930 0.00330 0.08500 0.00150 0.07600 0.01500
11 0.02300 0.00910 0.01900 0.00870 0.08800 0.01390 0.07600 0.01500
12 0.09700 0.01700 0.00990 0.00690
13 0.08400 0.01800 0.00980 0.00640
14 0.11300 0.08300 0.02900 0.00930
15 0.07200 0.03800 0.04000 0.00140 0.08100 0.00160 0.06100 0.00890
16 0.03800 0.00840 0.00870 0.00390 0.05900 0.00920 0.03200 0.00810
17 0.08500 0.00950 0.07100 0.00840
18 0.10900 0.00960 0.02600 0.00800 0.09500 0.00190 0.06400 0.00980
19 0.06500 0.00990 0.05500 0.00760
PARKINSON’S DISEASE
20 0.00910 0.07300 0.00630 0.01700 0.00930 0.03400 0.01250 0.02000
21 0.00910 0.08800 0.00930 0.05100 0.00100 0.00940 0.00630 0.01080
22 0.00790 0.06600 0.00550 0.01500
23 0.00180 0.05300 0.00230 0.00850
24 0.00800 0.08100 0.00930 0.01670 0.00160 0.03500 0.01900 0.05400
25 0.00210 0.05800 0.00710 0.07300 0.00730 0.02700 0.00970 0.02200
CIGARETTE SMOKERS
26 0.06800 0.00920 0.05200 0.00850 0.09500 0.00930 0.07400 0.00810
27 0.09100 0.01600 0.05900 0.00920 0.11700 0.00810 0.09300 0.00690
28 0.08400 0.00990 0.07300 0.00780 0.09800 0.00870 0.08300 0.00730
29 0.09800 0.02300 0.06120 0.00810 0.16800 0.00870 0.09200 0.00820
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Sa`etak
RADONOVE K]ERI U OKOLIŠU KAO POKAZATELJI BIOKEMIJSKIH
PROMJENA U MOZGU BOLESNIKA S ALZHEIMEROVOM I
PARKINSONOVOM BOLESTI I U PU[A^A
Odredili smo radioaktivnost radonovih k}eri, 210Po (alfa ~estice) i 210Bi (beta-~estice) u lipidima i proteinima iz sive
mase korteksa i bijele supkortikalne supstancije iz frontalnog i temporalnog re‘nja mozga osoba oboljelih od
Alzheimerove ili Parkinsonove bolesti, pu{a~a i nepu{a~a bez klini~kih znakova neurolo{ke bolesti. Ustanovili smo
da je radioaktivnost 210Pb i 210Bi bila deset puta ve}a selektivno u proteinima sive i bijele mo‘dane supstancije
osoba oboljelih od Alzheimerove bolesti i u pu{a~a. Za razliku od toga, radioaktivnost radonovih k}eri bila je
selektivno deset puta ve}a u lipidima sive i bijele supstancije mozga osoba oboljelih od Parkinsonove bolesti. Alfa
~estice visoke energije predstavile su se kao neizbje‘ni ~imbenik rizika iz prirodnog okoli{a za ~ovjekov mozak koji
zajedno s popratnim stvaranjem slobodnih radikala mogu dovesti do minimalne lokalne udru‘ene radiokemijske
ozljede mo‘danih stanica, najvjerojatnije astrocita. Rezultati pokazuju da patognomoni~na distribucija afiniteta
radonovih k}eri za lipide u bolesnika s Parkinsonovom bolesti i za proteine u bolesnika s Alzheimerovom bolesti
odra‘ava pove}anu prisutnost lokalno raspolo‘ivih klornih iona za koje se radonove k}eri selektivno ve‘u. Mislimo
da promjene u sastavu proteinskih pora, kanala i vrata ugra|enih u stani~nu membranu u bolesnika s
Alzheimerovom bolesti, kao i promjene propusnosti dvoslojnoga lipidnog sloja te iste membrane le‘e u biti tih dviju
te{kih sistemskih bolesti ~ovjekova mozga.
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